Rexulti (brexpiprazole) is a brand-name drug prescribed for certain mental health conditions. Rexulti comes as an oral tablet that’s typically taken once per day. The dosage can vary depending on what ...
PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the ...
Please provide your email address to receive an email when new articles are posted on . Approval makes Rexulti the lone treatment approved for agitation associated with Alzheimer’s dementia. Two FDA ...
On its May 10 PDUFA date, the U.S. FDA approved serotonin-dopamine modulator Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. and H. Lundbeck A/S for agitation in Alzheimer’s disease ...
Brexpiprazole tablets are indicated as an adjunctive therapy to antidepressants for the treatment of major depressive disorder and for the treatment of schizophrenia. Alembic has received the Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback